Channel Expansion Leverage GlycoMark's exclusive regional supplier status to accelerate distribution by partnering with regional laboratories and hospital systems. Develop a scalable channel strategy with clear value propositions, physician education, and payer engagement to boost adoption across markets.

APAC Access Tap into the Asia Pacific advantage created by joint ownership to access established supply chains and regulatory channels. Engage Toyota Tsusho and Nippon Kayaku affiliates to identify distributor opportunities, co brand, and align regulatory and reimbursement pathways for faster regional expansion.

SGLT-2 Synergy Position GlycoMark as a key tool for monitoring patients on SGLT-2 inhibitors, prioritizing endocrinology clinics and diabetes care programs. Build practical evidence through studies and education campaigns, and explore partnerships with pharmaceutical companies to incorporate GlycoMark into monitoring workflows.

Lab Partner Growth Expand the existing lab distribution footprint by recruiting additional clinical labs and providing live education support. Develop partner programs and incentives to accelerate adoption, using the company’s educational resources to increase clinician awareness.

Co-Development Opportunities Highlight GlycoMark’s capabilities for biomarker discovery and new test methodologies to attract co development and licensing opportunities. Engage biotech partners and contract research organizations in joint development initiatives to broaden the product portfolio.